COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02959047
Recruitment Status : Recruiting
First Posted : November 8, 2016
Last Update Posted : October 11, 2018
Northwestern University
Information provided by (Responsible Party):
Christopher Kramer, University of Virginia

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 17, 2020
Estimated Study Completion Date : July 17, 2021